Corcept Therapeutics Inc (NASDAQ: CORT) open the trading on Wednesday, with a bit cautious approach as it glided -8.83% to $83.81, before settling in for the price of $91.93 at the close. Taking a more long-term approach, CORT posted a 52-week range of $20.84-$117.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 17.73%. Meanwhile, its Annual Earning per share during the time was 9.89%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 37.80%. This publicly-traded company’s shares outstanding now amounts to $105.11 million, simultaneously with a float of $93.19 million. The organization now has a market capitalization sitting at $8.84 billion. At the time of writing, stock’s 50-day Moving Average stood at $63.90, while the 200-day Moving Average is $48.79.
Corcept Therapeutics Inc (CORT) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Corcept Therapeutics Inc’s current insider ownership accounts for 11.68%, in contrast to 80.20% institutional ownership. According to the most recent insider trade that took place on Mar 31 ’25, this organization’s insider sold 100,000 shares at the rate of 100.54, making the entire transaction reach 10,054,010 in total value, affecting insider ownership by 85,622. Preceding that transaction, on Apr 01 ’25, Company’s insider sold 590 for 114.55, making the whole transaction’s value amount to 67,584. This particular insider is now the holder of 85,622 in total.
Corcept Therapeutics Inc (CORT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.38 per share during the current fiscal year.
Corcept Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 37.80% and is forecasted to reach 3.34 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 70.53% through the next 5 years, which can be compared against the 9.89% growth it accomplished over the previous five years trading on the market.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Let’s observe the current performance indicators for Corcept Therapeutics Inc (CORT). It’s Quick Ratio in the last reported quarter now stands at 3.26. The Stock has managed to achieve an average true range (ATR) of 8.35. Alongside those numbers, its PE Ratio stands at $67.97, and its Beta score is 0.17. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 13.10. Similarly, its price to free cash flow for trailing twelve months is now 45.14.
In the same vein, CORT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.23, a figure that is expected to reach 0.14 in the next quarter, and analysts are predicting that it will be 3.34 at the market close of one year from today.
Technical Analysis of Corcept Therapeutics Inc (CORT)
[Corcept Therapeutics Inc, CORT] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 67.46% While, its Average True Range was 10.74.
Raw Stochastic average of Corcept Therapeutics Inc (CORT) in the period of the previous 100 days is set at 50.94%, which indicates a major rise in contrast to 47.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 325.98% that was higher than 133.32% volatility it exhibited in the past 100-days period.
